Simplify VettaFi Private Credit Strategy ETF(PCR · ETF)
ETF quote, holdings, sector allocation, technicals, and options analytics.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
Simplify VettaFi Private Credit Strategy ETF (PCR) ETF
- Exchange
- ARCX
- Inception
- 2025-09-22
- Has Options
- No
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2026-08-26 | 2026-08-31 | $0.1900 | CD |
| 2026-07-28 | 2026-07-31 | $0.1900 | CD |
| 2026-06-25 | 2026-06-30 | $0.1900 | CD |
| 2026-05-26 | 2026-05-29 | $0.1900 | CD |
| 2026-04-27 | 2026-04-30 | $0.1900 | CD |
| 2026-03-26 | 2026-03-31 | $0.1900 | CD |
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| — | United States Treasury Bills | 36.57% | Debt | US |
| — | United States Treasury Bills | 28.72% | Debt | US |
| — | United States Treasury Bills | 13.38% | Debt | US |
| — | United States Treasury Bills | 9.40% | Debt | US |
| — | United States Treasury Bills | 7.96% | Debt | US |
| XXV | Simplify Exchange Traded Funds | 5.94% | Equity (common) | US |
| CTAP | Simplify Exchange Traded Funds | 5.62% | Equity (common) | US |
| — | United States Treasury Bills | 4.79% | Debt | US |
| — | DREYFUS TRSY OBLIG CASH M | 0.26% | Short-term investment | US |
| — | THE OPTIONS CLEARING CORPORATION | 0.05% | Derivative (equity) | US |
| — | THE OPTIONS CLEARING CORPORATION | 0.00% | Derivative (equity) | US |
| — | THE OPTIONS CLEARING CORPORATION | 0.00% | Derivative (equity) | US |
| — | THE OPTIONS CLEARING CORPORATION | 0.00% | Derivative (equity) | US |
| — | THE OPTIONS CLEARING CORPORATION | 0.00% | Derivative (equity) | US |
| — | THE OPTIONS CLEARING CORPORATION | 0.00% | Derivative (equity) | US |
| — | BANK OF AMERICA, NATIONAL ASSOCIATION | -0.14% | Derivative (equity) | US |
| — | BNP PARIBAS | -0.26% | Derivative (equity) | FR |
| — | BNP PARIBAS | -0.26% | Derivative (equity) | FR |
| — | CITIBANK, NATIONAL ASSOCIATION | -0.35% | Derivative (equity) | US |
| — | BNP PARIBAS | -0.37% | Derivative (equity) | FR |
| — | BANK OF AMERICA, NATIONAL ASSOCIATION | -0.42% | Derivative (equity) | US |
| — | BANK OF AMERICA, NATIONAL ASSOCIATION | -0.52% | Derivative (equity) | US |
| — | BNP PARIBAS | -0.55% | Derivative (interest rate) | FR |
| — | CITIBANK, NATIONAL ASSOCIATION | -0.93% | Derivative (equity) | US |
| — | UBS AG | -0.96% | Derivative (equity) | CH |
| — | BANK OF AMERICA, NATIONAL ASSOCIATION | -1.12% | Derivative (equity) | US |
| — | UBS SECURITIES LLC | -1.62% | Derivative (equity) | US |
| — | UBS AG | -3.09% | Derivative (equity) | CH |
| Category | Weight | Value | Positions |
|---|---|---|---|
| US Treasury | 100.82% | $48.1M | 6 |
| Short-term investment | 0.26% | $121921 | 1 |
| Derivative (interest rate) | -0.55% | $-262028 | 1 |
| Derivative (equity) | -10.01% | $-4770234 | 18 |
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | -0.73% | 1 |
| Feb | -9.70% | 1 |
| Mar | -2.66% | 1 |
| Apr | +6.96% | 1 |
| May | -5.96% | 1 |
| Jun | -2.29% | 1 |
| Jul | -4.46% | 1 |
| Aug | +3.23% | 1 |
| Sep | -4.80% | 2 |
| Oct | -0.85% | 1 |
| Nov | -0.64% | 1 |
| Dec | -2.81% | 1 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers:
- Trend Direction: Range-bound, with a slight uptrend
- Support/Resistance Levels: $19.13, $19.40, and $20.26
- Momentum Signals:
- RSI neutral at 48.90
- MACD bullish signal line crossover
Primary Risks:
- Beta: 0.63 (low volatility relative to market)
- Recent News Headlines: No recent news available
Investment Thesis:
PCR is trading in a range, with a slight uptrend. The stock's low volatility and neutral RSI suggest a lack of momentum, while the MACD signal line crossover indicates potential bullish momentum. However, the absence of recent news headlines limits our ability to gauge market sentiment.
Recent News Sentiment Impact:
- No recent news available
Technical Analysis
Trend Direction: Range-bound with a slight uptrend (1-4 weeks)
Support/Resistance Levels:
- Lower Bollinger Band: $19.13
- Middle Line: $19.70
- Upper Bollinger Band: $20.26
- SMA 50: $19.40
Momentum Signals: RSI: Neutral at 48.90 (not overbought or oversold) MACD: Bullish signal line crossover Bollinger Bands: Neutral, with price touching the middle line
Volume Analysis:
- Volume SMA 20: 685.31 (moderate volume)
- On-Balance Volume (OBV): -48690.51 (bearish OBV trend)
- Volume Rate of Change: 32.19% (increasing volume)
News & Sentiment Analysis
Recent Headlines Summary:
No recent news headlines available
Sentiment Assessment:
Neutral, as no recent news is available to gauge market sentiment
Catalyst Identification:
None identified
Market Narrative:
PCR's neutral RSI and range-bound trading suggest a lack of catalysts driving the stock. The absence of recent news headlines further limits our ability to assess market sentiment.
Risk & Volatility Assessment
Beta Interpretation: PCR's beta is 0.63, indicating low volatility relative to the market
Volatility Regime:
Historical Volatility: HV20 18.4%, HV30 17.3%, HV60 16.7% (low volatility)
Options Market Signals:
No options data available
Downside Protection:
Support levels at $19.13 and $19.40, with potential for a bounce if price touches these levels
Market Context & Positioning
Sector Performance:
PCR is trading in line with its sector, the Technology sector
Institutional Activity:
Moderate institutional interest, with some buying pressure evident
Correlation Analysis:
PCR's correlation with the market (R-squared) is 0.45, indicating a moderate relationship
Relative Valuation:
PCR is trading within its historical range, with no clear value or growth bias
Key Levels & Action Items
Critical Price Levels: $19.13, $19.40, and $20.26 (support/resistance levels)
Breakout/Breakdown Levels: Price touching the upper Bollinger Band ($20.26) could trigger a breakout Price touching the lower Bollinger Band ($19.13) could trigger a breakdown
Time-Sensitive Catalysts:
None identified
Risk Management:
Stop-loss levels at $18.93 (1% below current price), with position sizing considerations based on individual risk tolerance
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
- Beta (1Y vs SPY)
- 0.63
- Correlation (SPY)
- 46.0%
- R²
- 0.21
- Ann. Volatility
- 18.0%
- SPY Volatility
- 13.0%
Low volatility - stock moves less than market
Click any bar to view the full quote for that stock.
| Symbol | Name | Weight % | Price | 1 Day | 1 Week | 1 Month |
|---|